The European Patent Office (EPO) has published patent application EP2026030180A1, detailing a method for optimizing Vero cell growth. This application, classified under C12N 7/00 and related IPC codes, is a new publication and does not represent an enforcement action or a rule change.

This patent publication is primarily of interest to entities involved in biotechnology research and development, particularly those manufacturing or developing pharmaceuticals and vaccines that utilize cell culture techniques. While this is a patent publication and not a regulatory mandate, it may inform R&D strategies and intellectual property considerations for companies in the sector.